E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/24/2005 in the Prospect News Biotech Daily.

Maxim agrees to forgive $2.8 million loan

By Kimberly N. Alleyne

Stroudsburg, Pa., Aug. 24 - Maxim Pharmaceuticals Inc. said it agreed to forgive a $2.8 million loan to former chairman and chief executive officer Larry G. Stambaugh.

The loan was made under a full recourse, interest bearing, secured revolving promissory note from Stambaugh Dec. 8, 2000.

The company decided that due to its inability to collect on the loan and in the interests of stockholders and creditors, it would be best to forgive the debt.

The agreement also prevents Stambaugh from making any further claims against Maxim and releases any present claims.

The loan amount had been written down to $264,000 as of June 30. Stambaugh forfeited all shares of common stock and 1.5 million options to purchase Maxim common stock.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.